Events › Healthcare & MedTech
Healthcare & MedTech
150
Exhibitors
9,000
Attendees
The Liver Meeting is the premier clinical and scientific event in hepatology, gathering leading global experts to present cutting-edge breakthroughs in liver disease research, practical tools for patient care, and a robust network shaping liver health.
Attendees: Hepatologists, gastroenterologists, basic scientists, surgeons, pharmacists, and healthcare professionals from over 80 countries.
Exhibitor mix: The floor plan features Category Pavilions alongside premium Business Suites and turnkey Start-Up Kiosks to group specialized medical products and new market entrants together.
Filter this event to your ICP.
150 exhibitors here. You probably care about 20–30. Tell us your ICP, we'll find them.
Request intelligence →Delivery within 24 hours · $1,250
Venue
Colorado Convention CenterConvention centre · 55,277 m² · 3 halls · ~10,000 people
A major convention center in downtown Denver, featuring over 55,000 sqm of exhibition space, a 5,000-seat auditorium, and extensive meeting rooms, managed by ASM Global.
📍 700 14th St, Denver, CO 80202, USA
Operated by ASM Global
Organizer
American Association for the Study of Liver DiseasesNonprofit · Alexandria, United States · Founded 1950
Medical society focused on researching, preventing, and treating liver diseases.
Exhibitor list
113 companies are exhibiting at The Liver Meeting. A sample of 12 is shown below — unlock the full list to see all 113.
101 more exhibitors at The Liver Meeting.
Unlock the complete exhibitor list — every company, with optional ICP filtering and verified buying-committee contacts per matched account.
Why people attend
To access emerging therapeutic research, evaluate the latest diagnostic technologies, establish clinical partnerships, and participate in peer-reviewed scientific and medical presentations.
Exhibitor categories
Speakers
29 speakers at The Liver Meeting
Discussion Leader · University of Kansas Medical Center
"MTE #4 Programmed Cell Death: Mechanisms and Pathways (Ticketed)"
Discussion Leader · Emory University
"MTE #4 Programmed Cell Death: Mechanisms and Pathways (Ticketed)"
"Screening for Hepatocellular Carcinoma in 2026 and Beyond—Challenges for Clinical Research"
Moderator
"Screening for Hepatocellular Carcinoma in 2026 and Beyond—Challenges for Clinical Research"
"Noninvasive Tools for Compensated Advanced Chronic Liver Disease and Portal Hypertension—Use in Daily Clinical Practice"
Moderator
"Clinical Research Workshop, Part 2A"
Chair · AASLD
"MASLD, MetALD, and ALD: Challenges and Opportunities"
Chair · AASLD
"MASLD, MetALD, and ALD: Challenges and Opportunities"
M.D. · Toronto General Hospital
"Transforming Chronic Liver Disease: Breakthroughs and Clinical Updates in Ribonucleic Acid Nanotherapeutics"
PhD · UMass Chan Medical School
"The Art and Science of Therapeutic Ribonucleic Acid Design"
"Recompensation in Alcohol-Associated Liver Disease—Predictive Factors, Management, and Gaps in Knowledge for Future Research"
PhD · The Regents of the Univ. of Calif., U.C. San Diego
"Ribonucleic Acid Nanomedicine in Liver Cancer Therapy"
University of Pennsylvania
"Strategies to Optimize Delivery of RNAi via Lipid Nanoparticles"
MD, FAASLD · University of Pittsburgh
"RNA Nanomedicine Reveals Dynamic Impact on Tumor Zonation and Immunology: Tale of Targeting Beta-Catenin"
PharmD, PhD · Boston University, Boston Medical Center
"Development of Lipid Nanoparticles for targeted treatment of Liver Fibrosis"
MD, MHSc, FAASLD · University of California, San Diego
"Next-Generation Therapies: Ribonucleic Acid Nanomedicine in Liver Fibrosis and Metabolic Dysfunction-Associated Steatohepatitis"
+ 13 more speakers at this event.
More Healthcare & MedTech events
Frequently asked questions